Access cutting-edge rsv infection treatment through this clinical trial at a research site in Modesto. Study-provided care at no cost to qualified participants.
Access rsv infection specialists in Modesto at no cost
This study follows strict safety protocols and ethical guidelines
All study-related rsv infection treatment provided free
This Phase 1/2a trial is a randomized, placebo-controlled trial to evaluate the safety, tolerability and immunogenicity of two ascending doses (10\^6 PFU and 10\^7 PFU) of intranasal BLB-201 (a recombinant parainfluenza virus type 5) administered in infants (8-24 months of age) and children (18-59 months of age) who may or may not have had prior respiratory syncytial virus (RSV) infection.
Sponsor: Blue Lake Biotechnology Inc.
Check if you qualify for this rsv infection clinical trial in Modesto, CA
If you're searching for rsv infection treatment options in Modesto, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Modesto research site is actively enrolling participants for this clinical trial. You'll receive care from experienced rsv infection specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.